FdaApplication
ANDA 205319
Identifiers
- fda_app_no: ANDA205319
Properties
| Property | Value |
|---|---|
| applicant_name | BRECKENRIDGE PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2020-10-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | EQ 10MG BASE | TABLET;ORAL |
1 product